ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

640
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
bearishCelltrion Inc
02 Apr 2020 03:56

Celltrion Block Deals: Weirdest One to Date

Let's first recap on how the bankers structured these block deals. The discount is quite generous: 8~9.8% for Celltrion and 7~8.8% for Healthcare....

Logo
477 Views
Share
bullishCelltrion Inc
01 Apr 2020 20:13

Block Deal Sales of Celltrion & Celltrion Healthcare Stakes by ION Investments

It was reported after the market close today that GIC's investment affiliate ION Investments has put up its shares in Celltrion Inc (068270 KS) and...

Logo
514 Views
Share
bearishCelltrion Inc
01 Apr 2020 17:32

Celltrion+Celltrion Healthcare Placement- Discount Looks Enticing but the Deal Appears Opportunistic

Temasek plans to raise US$380m via selling 1.9% stake in Celltrion Healthcare (091990 KS) and another US$132m via selling a 1.5% stake in Celltrion...

Logo
487 Views
Share
01 Apr 2020 05:39

Short Covering Continues - Celltrion Leads The Way

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 27 March 2020, the...

Logo
502 Views
Share
31 Mar 2020 17:32

Korea Stock Market Monthly Recap #46 (March 2020)

The world will never be the same after COVID-19. We provided an extensive analysis of the on-going developments of COVID-19 in March. This novel...

Logo
400 Views
Share
x